Background: The presence of emphysema is relatively common in patients with fibrotic
interstitial lung disease. This has been designated combined pulmonary fibrosis and …

Background There is an urgent need for biomarkers to better stratify patients with idiopathic
pulmonary fibrosis by risk for lung transplantation allocation who have the same clinical …

Cigarettes are well-recognized risk factors responsible for the emergence of a variety of
pathologic conditions affecting both the airways and the lungs. Smoking-related lung …

Idiopathic pulmonary fibrosis (IPF) is a chronic and devastating disease of unknown
etiology, characterized by irreversible morphological changes, ultimately leading to lung …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease. The
pathogenesis of interstitial lung diseases, including its most common form, IPF, remains …

Objectives To determine whether computer-based CT quantitation of change can improve
on visual change quantification of parenchymal features in IPF. Methods Sixty-six IPF …

Background Disease heterogeneity in idiopathic pulmonary fibrosis (IPF) often complicates
the systematic study of disease, management of patients and clinical investigations …

Background Cigarette smoking and occupational exposures each have been reported to
increase the risk of idiopathic pulmonary fibrosis (IPF), a disease previously considered of …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease of unknown cause,
occurring in adults, limited to the lungs and associated with the pathologic and radiologic …

Background Combined pulmonary fibrosis and emphysema (CPFE) is a novel clinical entity
with a poor prognosis. This study aimed to develop a clinical nomogram model to predict the …